Non-antibody scaffolds are increasingly used to generate novel binding proteins for both research and therapeutic applications. Our group has developed the tenth fibronectin type III domain of human tenascin-C (TNfn3) as one such scaffold. As a scaffold, TNfn3 must tolerate extensive mutation to introduce novel binding sites. However, TNfn3's marginal stability (T m ∼ 598 8 8 8 8C, DG unfolding 5 5.7 kcal/mol) stands as a potential obstacle to this process. To address this issue, we sought to engineer highly stable TNfn3 variants. We used two parallel strategies. Using insights gained from structural analysis of other FN3 family members, we (1) rationally designed stabilizing point mutations or (2) introduced novel stabilizing disulfide bonds. Both strategies yielded highly stable TNfn3 variants with T m values as high as 838 8 8 8 8C and DG unfolding values as high as 9.4 kcal/mol. Notably, only three or four mutations were required to achieve this level of stability with either approach. These results validate our rational design strategies and illustrate that substantial stability increases can be achieved with minimal mutation. One TNfn3 variant reported here has now been successfully used as a scaffold to develop two promising therapeutic molecules. We anticipate that other variants described will exhibit similar utility.
Introduction
Engineered binding proteins comprise the vast majority of biotherapeutics currently in development. The binding sites of these molecules are created by mutating residues in a contiguous patch of surface on a protein that serves as a molecular scaffold. Although antibodies remain the most prevalent example of such a protein scaffold, alternative, non-antibody scaffolds have become increasingly prominent (Gebauer and Skerra, 2009; Koide, 2010) . A successful scaffold protein must have sufficient stability to tolerate the often extensive modification required to introduce a new binding site. Most nonantibody scaffolds are small, single domain proteins. As a result, a significant percentage of the protein surface may be mutated in these systems, making a high level of starting stability all the more important. One generalized benchmark that has been suggested for starting stability in a small nonantibody scaffold is a T m . 608C (Skerra, 2007) . The most successful alternative scaffolds to date all meet this benchmark with some far surpassing it (Litvinovich and Ingham, 1995; Koide et al., 1998; Schlehuber and Skerra, 2002; Wetzel et al., 2008) .
One protein domain that has been particularly successful as a non-antibody scaffold is the fibronectin type III (FN3) domain. The FN3 domain is a member of the immunoglobulin superfamily and correspondingly has three surface exposed loops at one end of the molecule that are analogous to antibody complementarity determining regions. Typically, the amino acid sequences of these loops, sometimes in combination with other regions, are modified to create novel binding sites. The most prominent example of an FN3 scaffold is the tenth fibronectin type III domain of human fibronectin (FNfn10) (Koide et al., 1998 (Koide et al., , 2012a Bloom and Calabro, 2009) . Our group has developed another FN3 family member, the third fibronectin type III domain of human tenascin-C (TNfn3) as a scaffold (Oganesyan et al., 2013; Swers et al., 2013) . TNfn3 and FNfn10 are essentially identical in overall structure (Fig. 1A) , and given the success of the FNfn10 platform, one would expect TNfn3 to make an effective scaffold as well. However, despite their structural similarities, TNfn3 (T m ¼ 598C, DG unfolding ¼ 5.7 kcal/mol) is substantially less stable than FNfn10 (T m ¼ 888C, DG unfolding ¼ 7.2 kcal/mol) (Litvinovich and Ingham, 1995; Koide et al., 1998 ). FNfn10's high degree of stability helps it tolerate the mutations and insertions/deletions necessary to introduce novel binding sites into the small scaffold (Litvinovich and Ingham, 1995; Koide et al., 1998; Batori et al., 2002) . The lower stability of TNfn3 stands as a potential liability for the system, and fails to meet the minimum benchmark for starting stability suggested above.
The folding and stability of TNfn3 have been well-studied and some efforts to increase its stability have also been reported. Strickler et al. (2006) used a computational algorithm to identify mutations that would stabilize TNfn3 by optimizing charge interactions on the protein surface. From this approach the authors identified a quadruple mutant (Q7K, L19K, D49K, T89K) that exhibited an improved T m of 668C. In other computational work, the entire TNfn3 sequence was redesigned to optimize it for the native backbone structure. These efforts also successfully yielded stabilized variants with T m of 80-908C and DG unfolding ¼ 8.7-11.9 kcal/mol (Dantas et al., 2003; Hu et al., 2008) . In additional related work, Jacobs et al. (2012) used a consensus design strategy to † This work is dedicated to the memory of Benoy M. Chacko generate highly stable FN3 domains. In this approach, a consensus sequence was derived from alignment of the 15 FN3 domains found in human tenascin-C. The tenascin consensus domain had significantly improved stability when compared with the natural FN3 domains from which it was derived (T m ¼ 788C, DG unfolding ¼ 10.6 kcal/mol) and this stability was further enhanced by additional point mutations (T m ¼ 92.78C, DG unfolding ¼ 15.5 kcal/mol).
Although effective, all of the approaches described above involved introducing several or many mutations at once. Thus, in all of these cases, the relative contributions of individual mutations remain unknown. As a result, it is unclear which mutations are required to maintain the enhanced stability and which mutations may be unnecessary. Because large portions of protein surface are often mutated when introducing novel binding sites into small scaffolds such as TNfn3, understanding which positions must remain fixed to maintain enhanced stability can be advantageous. Furthermore, unnecessary mutations away from the wild-type human sequence could increase immunogenicity risks in cases where the variant is used as a scaffold in the development of therapeutic molecules.
Here, we sought to engineer highly stable TNfn3 variants while also minimizing the number of mutations introduced. To achieve this goal, we used two approaches based in rational design. In the first approach, we looked for structural differences between TNfn3 and the more stable structural homolog FNfn10 that might account for TNfn3's comparatively reduced stability. We then designed mutations at these positions intended to mimic the structure of the more stable FNfn10. To supplement this effort, we also identified the most stabilizing individual mutations from among the group of four previously identified by Strickler et al. By combining just three or four of these mutations, we increased the T m of TNfn3 to as high as 838C and DG unfolding to as high as 9.4 kcal/mol. In a second strategy, we stabilized TNfn3 by introducing novel disulfide bonds. The locations of these engineered disulfides were inspired by naturally occurring disulfides in other FN3 domains. Using only 1 or 2 disulfides, this strategy similarly yielded highly stable TNfn3 variants with T m as high as 818C and DG unfolding to as high as 7.4 kcal/mol. Notably, one variant described here (SS4) has now been successfully deployed as a scaffold and has facilitated the development of two therapeutically promising molecules (Oganesyan et al., 2013; Swers et al., 2013) . We anticipate that the other variants identified here will have similar utility.
Materials and methods

Protein expression and purification
Double-stranded DNA fragments encoding wild-type TNfn3 and all described variants were obtained from Integrated DNA Technologies. Fragments were designed with flanking Nco I and Kpn I restriction sites which facilitated cloning into a pET22b-based bacterial expression vector (Novagen) between promoter elements and a sequence encoding a C-terminal His-tag (see protein sequence below). Sequences of all constructs were confirmed by DNA sequencing. The wild-type TNfn3 protein sequence from which all other constructs were derived was as follows: ARLDAPSQIEVKDVTDTTALITWFKPLAEIDGIELTYG IKDVPGDRTTIDLTEDENQYSIGNLKPDTEYEVSLISRR GDMSSNPAKETFTTGL [GGSGGTLEHHHHHH] Residues enclosed in brackets constitute a tag sequence used to facilitate purification by Ni affinity chromatography. An extra N-terminal alanine (underlined, italics) was also present due to the Nco I restriction site used for cloning. The initiator methionine was efficiently removed by bacterial processing and its absence in expressed proteins was confirmed by mass spectrometry.
Chemically competent E. coli BL21(DE3) (Lucigen) were transformed with the constructs described above and protein was produced by overnight growth in auto-inducing Magic Media (Invitrogen). Cells were harvested by centrifugation and the pellet was frozen to assist in cell lysis. After thawing, the pellet was resuspended in 50 mM Tris, pH ¼ 8.0, 1 mg/ml hen egg lysozyme, 20 mg/ml DNase I, and 1 mM phenylmethylsulfonyl fluoride. The suspension was incubated on ice for 30 min. NaCl was added to a final concentration of 500 mM and the lysate was clarified by two rounds of centrifugation at 18 000g at 48C. The cleared lysate was then loaded onto hand poured, gravity fed columns packed with Ni-NTA Superflow resin (Qiagen). The columns were rinsed with 20 column volumes of 50 mM Tris, 500 mM NaCl, pH ¼ 8.0. Bound proteins were eluted with 5 column volumes of 50 mM Tris, 500 mM NaCl, 500 mM imidazole, pH ¼ 8.0. Proteins were further purified by ion exchange using a HiTrap Q HP column (GE Healthcare). After Ni-NTA purification, proteins were dialyzed into 50 mM Tris, 50 mM NaCl, pH ¼ 8.0 and loaded onto a HiTrap Q HP column equilibrated in the same buffer. The column was rinsed with 5 column volumes of 50 mM Tris, 50 mM NaCl, pH ¼ 8.0 (buffer A) and then proteins were eluted with a 0 -50% gradient of buffer B (50 mM Tris, 1 M NaCl, pH ¼ 8.0) achieved over 10 column volumes. Protein elution was followed by monitoring absorbance at 280 nm and protein containing-fractions were collected. Fractions were analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and those containing TNfn3 protein were pooled. Final protein purity was confirmed by SDS-PAGE, concentrations were determined by absorbance at 280 nm and protein masses were confirmed by electrospray mass spectrometry.
Refolding of disulfide containing variants
Disulfide-containing TNfn3 variants were purified as outlined above using Ni affinity chromatography. Proteins were then diluted to a final concentration of 0.5 mg/ml in 6 M guanidine HCl, 20 mM dithiothreitol (DTT), 50 mM Tris pH ¼ 8.0 and incubated for 1 h at room temperature. Samples were then exhaustively dialyzed against 0.5 M guanidine HCl, 5 mM cysteine, 1 mM cystine, 50 mM Tris pH ¼ 8.0, and subsequently dialyzed into 10 or 50 mM potassium phosphate, 50 mM NaCl, pH ¼ 7.4. Disulfide formation was probed by reverse phase high performance liquid chromatography (RP-HPLC) as described below.
RP-HPLC analysis of disulfide bond formation
Protein samples were mixed 1 : 1 with 6 M Guanidine HCl, 50 mM Tris, pH ¼ 8.0 and incubated for 1 h. DTT was also added to a final concentration of 10 mM for reduced samples. Samples were then injected onto a C4 analytical HPLC column (Grace). A mobile phase of 0.1% v/v trifluoroacetic acid (TFA) was used with an acetonitrile gradient (0 -60%) for sample separation. A flow rate of 1 ml/min was used for sample elution. Protein elution was monitored by following absorbance at 280 nm.
Size exclusion chromatography
Twenty-five microliters of 1 mg/ml protein in 10 or 50 mM potassium phosphate, 50 mM NaCl pH ¼ 7.4 was loaded onto a Superdex75 5/150 GL column (GE Healthcare) equilibrated with 20 mM potassium phosphate, 150 mM NaCl pH ¼ 7.4. Proteins were eluted at a flowrate of 0.15 ml/min using the same buffer. Protein elution was followed by monitoring absorbance at 280 nm.
Differential scanning calorimetry
For differential scanning calorimetry (DSC) analysis, proteins were dialyzed into 10 mM potassium phosphate, 50 mM NaCl, pH ¼ 7.4, and diluted to a final concentration of 100 mM in the same buffer. For reduced SS3 and SS4 samples only, protein solutions were diluted 1 : 1 with 6 M guanidine HCl, 50 mM DTT, 50 mM potassium phosphate, pH ¼ 7.4 and incubated at room temperature for 2 h. These samples were then dialyzed into 10 mM HEPES, 50 mM NaCl, 2 mM tris(2-carboxyethyl) phosphine (TCEP), pH ¼ 7.4 and concentrations adjusted to 100 mM. TCEP was chosen as a reducing agent for these samples in lieu of DTT and b-mercaptoethanol, which had severe effects on the DSC baseline and failed to fully reduce the disulfide bonds respectively. HEPES buffer was used to accommodate TCEP which is less stable in phosphate buffers (Han and Han, 1994) . Samples were analyzed using a VP-DSC (MicroCal, LLC). Samples were heated from 30 to 1108C using a scan rate of 908C/h. Buffer blank and progress baselines were subtracted from all data. All samples exhibited .80% reversibility, as assayed by cooling, reheating and comparing recovery of DH cal values derived from integration of the transition peak. All samples showed DH cal /DH VH (Van't Hoff Enthalpy) 1, so for final analysis, curves were fit to a simple 2-state model to derive T m and DH m using analysis software provided by the manufacturer.
Denaturant titrations
Protein samples were dialyzed into 50 mM potassium phosphate, 50 mM NaCl, pH ¼ 7.4 and diluted to a final concentration of 5 mM in varying concentrations (0 -3 M) of guanidine thiocyanate (GdnSCN), 50 mM potassium phosphate, 50 mM NaCl, pH ¼ 7.4. After mixing, all samples were incubated at room temperature (238C) for at least 24 h. Fluorescence emission spectra (310 -400 nm) were then recorded with a Fluoromax-4 Spectrofluorometer (Horiba Jobin Yvon) at 238C using an excitation wavelength of 295 nm. Denaturation curves were constructed by plotting fluorescence intensity vs.
[GdnSCN] at the wavelength that showed the largest change in intensity over the course of the titration (360 -370 nm). Data were then fit to a two-state model as previously described to derive m-values, DG unfolding , and [D] 50% (Santoro and Bolen, 1988 ) using GraphPad Prism 6 software.
Protease stability assays
Proteins were diluted to a final concentration of 50 mM in 20 mM Tris, 150 mM NaCl, 10 mM CaCl 2 , pH ¼ 8.0 and thermolysin (MP Biopharmaceuticals) was added at a final concentration of 0.2 mg/ml. Samples were then incubated at 428C for varying amounts of time. At each time point, reactions were quenched by addition of EDTA to a final concentration of 100 mM. Samples were then analyzed by reducing SDS-PAGE.
Results
Stabilizing TNfn3 by point mutation
Although TNfn3 and the more stable homolog FNfn10 share only 24% sequence identity, they share an essentially identical overall structure (Fig. 1A and B) . Thus, we first looked to FNfn10 to provide clues as to how TNfn3 might be made more stable. Previous studies have shown that swapping the hydrophobic core residues of FNfn10 with those of TNfn3 results in significant destabilization, suggesting that features of the FNfn10 core contribute to its increased stability (Billings et al., 2008) . While this same work implicated surface residues as important contributors to stability as well, we chose to focus our efforts toward residues in the hydrophobic core.
By many measures, the hydrophobic cores of TNfn3 and FNfn10 are very similar. Most core residues bury a similar percentage of their surface in the two proteins and also exhibit a similar number of contacts. Furthermore, the TNfn3 and FNfn10 cores bury similar amounts of total surface (Billings et al., 2008) . However, the two homologs do show some structural differences. Perhaps most striking are differences in A/G strand packing (Fig. 1C) . In FNfn10, the A and G strands pack together efficiently through tightly interdigitating hydrophobic residues. In contrast, in TNfn3, a charged glutamate is substituted at position 86 in the center of the G strand, despite the fact that this position points inward toward the hydrophobic core. This is the most non-conservative substitution in the TNfn3 core compared with FNfn10. E86 is unsurprisingly less buried than the equivalent I90 in FNfn10 since its carboxylic acid group is pointed outward toward solvent and the result is an apparent 'peeling apart' of the b-sandwich in this area. Consistent with an unfavorable effect of glutamic acid at position 86, previous studies showed that an E86A mutation stabilizes TNfn3 by 1.6 kcal/mol (Cota et al., 2000) . Additionally, Jacobs et al. (2012) have cited unpublished data indicating that the E86I mutation increases the T m of TNfn3, though no further description or characterization of this mutant was reported. Packing in the A/G strand region is seemingly made worse by an alanine substitution at position 84 that appears unable to pack as densely as the bulkier isoleucine at the equivalent position 88 in FNfn10. Flawed packing at positions 84 and 86 of TNfn3 is also quantitatively supported by data from a previous analysis carried out by Cota et al. (2000) which showed that A84 and E86 make fewer interresidue contacts and bury a smaller percentage of their surface area than their counterparts in FNfn10. Inspired, by these apparent packing defects we made and characterized the stability of two TNfn3 mutants, A84V and E86I, designed to improve A/G strand packing and mimic the seemingly more optimal structure of FNfn10 (Fig. 1B and C) . DSC experiments showed that A84V improved the stability of TNfn3 only slightly, increasing the T m by 18C. However, E86I substantially improved stability, increasing the T m by 118C (Table I) .
The TNfn3 and FNfn10 core structures also differ near the heavily buried W22. W22 is the most conserved residue among FN3 family members, and even conservative substitution at this position is substantially or catastrophically destabilizing (Cota et al., 2000) . W22 makes extensive contacts with other core residues and is thought to be a part of the common 'folding nucleus' among FN3 domains (Cota et al., 2001) . Because of its importance, we reasoned that differences in the local environment and packing of W22 might have significant effects on TNfn3 stability. Although W22 is buried to a similar extent in TNfn3 and FNfn10, it makes fewer interresidue contacts in TNfn3 (Cota et al., 2000) . Structural examination shows that this is mostly due to a 'capping' interaction that exists between Y32 and W22 in FNfn10 that is absent in TNfn3 due to a Y to I substitution (Fig. 1C) . Across FN3 family members, Y/F is favored at position 32 and F in particular is favored among other FN3s in human tenascin. Thus, we reasoned that an I32F mutation might stabilize TNfn3 by improved packing with W22. DSC experiments revealed that the I32F mutant indeed modestly stabilized TNfn3 by 2.38C (Table I) .
As a supplement to the mutations identified above, we examined the effects of four previously reported surface charge optimizing mutations described by Strickler et al. (2006) (Q7K, L19K, D49K and T89K) when introduced independently (Fig. 1B) . Although simultaneous introduction of these mutations increased the T m of TNfn3 to 668C, previous work did not characterize the individual effects of these mutations, leaving open the possibility that a subset of them might yield a similar increase in stability while reducing the total number of mutations needed. DSC analysis revealed that D49K and T89K were clearly stabilizing as individual mutations, each increasing the T m by 58C compared with wild type (Table I) . Q7K was slightly stabilizing, increasing the T m by 18C and L19K was slightly destabilizing when introduced alone, decreasing the T m by 28C. These results indicate that the 108C increase in stability previously reported for the quadruple mutant is either mostly due to D49K and T89K, or that the effects of the individual mutations on stability are changed in the context of the quadruple mutant making them non-additive.
We next examined whether TNfn3 could be stabilized to a greater extent by combining multiple stabilizing mutations. We began with the most stabilizing mutation, E86I, and added the next most stabilizing mutations in succession. We chose FNfn10 as an approximate benchmark for stability given its success as an alternative scaffold and similarity to TNfn3. We therefore aimed for a T m . 808C using the fewest mutations possible. DSC analysis showed that a triple mutant termed CM3 (E86I, T89K, D49K) and a quadruple mutant termed CM4 (E86I, T89K, D49K, I32F) met this criteria with T m values of 81 and 838C, respectively (Table I) .
Stabilizing TNfn3 using disulfide bonds
As an alternative to the point mutation-based approach outlined above, we also explored whether TNfn3 might be stabilized by introducing one or more disulfide bonds. Disulfide bonds help to stabilize the native states of numerous proteins, and successful efforts to stabilize proteins through engineered disulfides have been reported for several systems (Perry and Wetzel, 1984; Matsumura et al., 1989; Kanaya et al., 1991; Betz, 1993; Mansfeld et al., 1997) . However, choosing where to introduce novel disulfides is non-trivial due to geometric requirements and the fact that many engineered disulfides, even if formed effectively, have been found to have no or negative effects on stability (Betz, 1993) . To help guide our efforts, we examined where disulfides tend to naturally occur in other FN3 family members. According to the latest release of the Structural Classification of Proteins-extended database (SCOPe) there are 146 structures in the PDB of FN3 domains having ,95% sequence identity (Fox et al., 2014) . Seventy five of the 146 contain cysteines, and 33 of these have modeled disulfides. We overlayed the structures of these 33 disulfide containing FN3s with the structure of TNFn3 to determine where disulfide bonds frequently occur in the FN3 fold, reasoning that such disulfide 'hotspots' might be well-suited for introducing novel disulfides in TNfn3. Because the data set was small, we considered any position where more than one FN3 domain exhibited a disulfide as a hotspot. However, we only considered disulfides connecting well-structured b-sheet regions, since loop conformations can vary widely across different FN3 family members, making introduction of an equivalent disulfide in TNfn3 difficult. Our analysis revealed four disulfide hotspots, termed SS1, SS2, SS3 and SS4 connecting the A/B, D/E, F/G and C/F strands, respectively ( Fig. 2A) . In an effort to mimic each of these disulfides, we made four double cysteine mutants, SS1, SS2, SS3 and SS4.
All four cysteine containing variants expressed well in Escherichia coli and were successfully purified in high yield. To facilitate disulfide bond formation, we unfolded the proteins in guanidine HCl and reduced all cysteines with DTT. We then refolded by dialyzing into low guanidine HCl buffer containing a cysteine/cystine redox pair to encourage disulfide formation. This was followed by a second dialysis step into standard buffer. To assess disulfide formation in each of the constructs, we used RP-HPLC (Fig. 2B) . The SS1, SS3 and SS4 variants, each showed a single peak when examined in the oxidized state. Upon addition of reducing agent, all three proteins still showed a single peak, but with a shift in elution time consistent with a change in chemical state, most likely because of disulfide bond reduction and extension of the polypeptide chain. Unlike these three proteins, SS2 showed multiple peaks in the oxidized state that collapsed into a single shifted peak upon addition of reducing agent. This heterogeneity is consistent with inefficient/incomplete disulfide bond formation. As a result SS2 was not pursued further. To further assert the homogeneity and examine the aggregation state of SS1, SS3 and SS4, we examined their behavior in size exclusion chromatography (Fig. 2C ). All three proteins showed monodisperse profiles and eluted at volumes identical to wild-type TNfn3 indicating that they were homogeneous and monomeric.
We next assessed the stability of SS1, SS3 and SS4, using DSC. These experiments showed that SS3 and SS4 were both stabilized compared with wild-type exhibiting T m values of 67.3 and 71.08C, respectively (Table I ). In contrast, SS1 was destabilized compared with WT exhibiting a T m of 50.68C. Thus, SS1 was not pursued further. To assert that disulfide bond formation was responsible for the increased stability of SS3 and SS4, we measured their T m values in the presence of reducing agent. Both mutants showed substantially reduced T m values that were even somewhat lower than wild-type TNfn3, confirming that disulfide formation was indeed responsible for the observed stability increase (Table I, Fig. 2D ). We next evaluated whether TNfn3 could be further stabilized by combining the SS3 and SS4 disulfides. We purified, refolded, and assessed disulfide formation and the aggregation state of the SS3,4 double disulfide mutant as described above ( Stabilization of TNfn3 by rational design and C). DSC experiments indeed showed that SS3,4 was further stabilized compared with SS3 or SS4 alone exhibiting a T m of 80.68C (Table I, Fig. 3A ).
Comparing TNfn3 variants stabilized by point mutation and disulfide methods
Both the point mutation and disulfide strategies resulted in TNfn3 variants that were stabilized to a similar degree, with the most stable variants from each approach, CM4 and SS3,4, exhibiting T m values of 82.6 and 80.38C, respectively (Table I , Fig. 3A) . In order to further examine the nature of these stability increases, and to assess whether the increases in T m translated to improved folding free energies, we performed denaturant titrations for CM4 and SS3,4 using guanidine thiocyanate (GdnSCN) at 238C and monitored unfolding by intrinsic tryptophan fluorescence (Fig. 3B, Table II ). Both CM4 and SS3,4 had increased [GdnSCN] 50% values compared with wild type, but SS3,4 exhibited a significantly higher [GdnSCN] 50% than CM4. Notably, the m-values for SS3,4 and CM4 also differ significantly (CM4 . SS3,4). This combination results in DG unfolding values for CM4 and SS3,4 of 9.45 and 7.21 kcal/mol, respectively. Thus, although SS3,4 has a higher [GdnSCN] 50% value, CM4 is more stable in terms of free energy of folding.
To further probe the nature of increased stability in CM4 and SS3,4, we assessed their resistance to proteolysis. The proteins were incubated with thermolysin for varying periods of time and their degree of degradation was assessed by SDS-PAGE. Because thermolysin preferentially cleaves at hydrophobic residues most often found in the hydrophobic core (i.e. I,L,F,V) thermolysin resistance can be reasonably regarded as reflecting the 'foldedness' of a protein sample (Heinrikson, 1977; Park and Marqusee, 2005; Minde et al., 2012) . We observed that all three samples showed a fast cleavage event which resulted in a small mass shift at early time points (Fig. 3C) . Mass spectrometry analyses revealed that this cleavage was the same for all samples including wild type and corresponded to the loss of a C-terminal tag sequence present in all of the constructs (data not shown). Thus, this initial cleavage event does not reflect the stability of the FN3 domain itself. At longer timescales, wild-type TNfn3 was almost completely degraded within 4 h (Fig. 3C ). In contrast, both CM4 and SS3/4 remained almost completely intact even after 24 h. Notably, however, at 48 h, SS3,4 showed a greater degree of degradation than CM4. Thus, these proteolysis experiments are consistent with chemical denaturation and DSC data and indicate that both CM4 and SS3,4 are substantially more stable than wild-type TNfn3, but CM4 is somewhat more stable than SS3,4.
Discussion
Here, we produced highly stable TNfn3 variants using just 3 or 4 total mutations. This small level of perturbation stands in contrast to other efforts that, although successful, have yielded proteins that are extensively mutated compared with wild-type TNfn3 (Dantas et al., 2003; Hu et al., 2008; Jacobs et al., 2012) . It is interesting to note that these more drastically altered proteins exhibit mutations at many of the same positions investigated here. However, large contextual differences make the relative importance of these mutations unclear.
The I32F, A84V and E86I mutations explored here were intended to improve packing of the A/G strands as well as optimize the environment of W22 in a way similar to that observed in the structure of FNfn10. Denaturant m-values are known to correlate with the amount of hydrophobic surface buried in the native state (Myers et al., 1995) . Although modest, the increased m-value of CM4 relative to wild-type TNfn3 is thus consistent with improved/expanded core packing (Table II) . While all three of the FNfn10-inspired mutations were stabilizing to some degree, the E86I mutation was particularly effective, increasing T m by 118C. The strong stabilizing effect of E86I suggests that differences in A/G strand interactions might be a significant contributor to the difference in stability between TNfn3 and FNfn10. Consistent with this notion, previous studies by Cota et al. (2000) identified stark differences between the two proteins in structural dynamics and response to mutation in this region.
The Q7K, L19K, D49K and T89K mutations examined here were previously reported, however, their effects had only been investigated in combination and their effects as individual mutations had not been characterized (Strickler et al., 2006) . While Q7K, D49K and T89K were all found to be stabilizing as individual mutations, L19K was found to be mildly (Santoro and Bolen, 1988). destabilizing indicating that it is either compensated for in the stabilized quadruple mutant, or that it requires the context of the other mutations to become stabilizing. Among the other mutations, D49K and T89K were particularly effective when introduced individually. Examining the TNfn3 structure, we suspect that both of these mutations act by neutralizing clusters of like charge. D49 is located across from E33 in the neighboring b-strand, possibly resulting in electrostatic repulsion. A similar juxtaposition of negatively charged sidechains in FNfn10 was found to be destabilizing, but could be ameliorated if one of the charges was reversed (Koide et al., 2001) . Similarly, T89 is located near the C-terminus and a cluster of negative charge previously implicated as potentially destabilizing (Meekhof et al., 1998) . We suspect that introduction of a positive charge into this cluster also helps to alleviate charge repulsions. In addition to our point mutation strategy, the disulfide engineering approach used here was also effective for stabilizing TNfn3. It is notable that disulfide engineering has also proven to be an effective strategy for stabilizing the CH2, CH3 and V H domains of human immunoglobulin and the camelid V H H domain (Saerens et al., 2008; Gong et al., 2009; Kim et al., 2012; Wozniak-Knopp et al., 2012; Ying et al., 2013) , all of which are close structural relatives to TNfn3 (all are members of the immunoglobulin superfamily). These engineered proteins have exhibited a wide range of T m increases spanning from as little as just a few 8C to as much as 358C. DDG unfolding values have been less commonly measured, but exhibit a similarly broad range 0 to 4 kcal/mol. Thus, the increases of 8.6 and 12.38C in T m for SS3 and SS4, respectively, and the DDG unfolding of 1.74 kcal/mol for SS3,4 would seem fairly typical on these admittedly broad scales.
The wide range of variability in the effectiveness of disulfide engineering is a feature that has been noted elsewhere (Betz, 1993) . Indeed, in some instances, engineered disulfides have thermodynamically destabilized proteins despite deceptive increases in T m (Betz and Pielak, 1992; Betz, 1993; Saerens et al., 2008) . Here, SS1 was destabilizing and SS2 did not form effectively providing additional examples of this variability. In hindsight, it seems likely that the SS2 disulfide formed inefficiently because the D and E strands are too far separated in TNfn3. When the SS2 disulfide does occur in homologous proteins, it is always accompanied by a substantial shift in the D strand toward the E strand, reducing this distance. The reasons for the destabilizing effect of SS1 are less clear. However, Cota et al. observed that the I20A mutation is severely destabilizing (DDG unfolding ¼ 23.67 kcal/mol). Indeed, among the 28 hydrophobic core residues investigated, only four other positions exhibit greater DDG unfolding values on mutation to alanine. Thus, the I20C mutation introduced in SS1 may be partly responsible for its destabilizing effects.
Both SS3 and SS4 were stabilizing, but SS4 was slightly more so (by T m ). We speculate that this may be because SS4 crosslinks two positions with greater separation in primary sequence leading to a greater decrease in chain entropy in the unfolded state (Fig. 1B and 2A) (Pace et al., 1988) . The most stable disulfide variant, SS3,4 exhibited a very similar T m value to CM4, but the two proteins differed markedly from each other in DH m with the value for SS3,4 being much smaller (69 vs. 106 kcal/mol, Fig. 3A , compare area of transition peaks). This difference would seem too large to be explained by DC p effects since the T m values of the two proteins only differ by 28C. Rather, these results indicate that compared with CM4, enthalpic interactions in SS3,4 are either reduced in the folded state or increased in the unfolded state. Relatedly, SS3,4 has a much lower m-value compared with CM4 (Table II) . Since m-values are known to correlate with the net amount of hydrophobic surface buried on folding (Myers et al., 1995) , the reduced m-value of SS3,4 also hints that hydrophobic packing is either disrupted in the folded state or increased in the unfolded state. Both scenarios seem plausible. The introduction of the SS4 disulfide into the protein core could very well disrupt core packing in the folded state. Alternatively, tethering points far from each other in primary sequence via a disulfide bond could result in increased residual structure in the unfolded state, leading to the decreased DH m and m-values. Other studies have shown that residual unfolded state structure can give a reduced DC p , which reflects many of the same properties as m-values (Betz and Pielak, 1992; Myers et al., 1995; Robic et al., 2003) . The upshot of SS3,4 exhibiting a reduced DH m value compared with CM4, despite a very similar T m , is that the calculated DS m value for SS3,4 is also significantly reduced compared with CM4 (198 vs. 295 cal/ mol K). Thus, in the context of thermal unfolding, although SS3,4 is less enthalpically stable than CM4, this is offset by a corresponding decrease in the entropic penalty of its folding leading to its very similar T m value. We speculate that this decrease in entropic penalty comes as a result of conformational restriction of the unfolded state by the engineered disulfides. Overall, our analyses indicate that although CM4 and SS3,4 are both substantially more stable than wild-type TNfn3, they achieve their increased stability through distinct thermodynamic mechanisms.
